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I. Introduction 
The essential micronutrient copper participates in several biological 
processes, like respiration, iron homeostasis, antioxidant defense or pigment 
formation. However, excess of copper can promote ROS formation and thus 
induce oxidative damages. Therefore, intracellular copper concentration is 
under strict control. Menkes and Wilson’s disease are genetic disorders 
causing impairment in copper homeostasis leading to copper deficiency or 
overload, respectively. Wilson’s disease is treated by chelation therapy, but 
the presently used drugs have several adverse side effects. New peptide or 
tripodal pseudopeptide ligands that display high affinity for the intracellular 
Cu(I) and target hepatic cells have been developed by Delangle et al. Some 
of them are currently proposed as highly specific drugs for localized copper 
chelation therapy in Wilson’s disease. 
II. Aims and objectives 
My Ph.D. work consisted of the design of three groups of cysteine 
containing peptides and the characterization of their Cu(I) complexes to 
determine whether they are appropriate candidates for the treatment of 
Wilson’s disease. The interaction of some peptides with Hg(II), which is a 
metal ion possessing similar coordination properties to Cu(I) and therefore 
an often used probe of the oxygen and water sensitive Cu(I), and with the 
ubiquitous Zn(II), which is a potential intracellular competitor, was also 
studied. 
The peptides were designed by three different approaches. In a first 
strategy, we attempted to take advantage of the outstanding selectivity and 
sensitivity of the bacterial copper efflux regulator protein CueR by studying 
oligopeptides based on the metal binding motif of CueR involving two 
cysteine residues (Figure 1). 
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Figure 1. Schematic structures of the CueR model peptides 
Second, three-cysteine containing linear and cyclic peptides (Figure 2) 
were designed with the aim of merging the advantages of peptides and tripods 
previously studied in the Delangle lab, namely the large Cu(I) binding affinity 
of tripodal pseudopeptides and the better internalization by the hepatocytes 
of peptide based molecules. 
 
Figure 2. Schematic representation of the three-cysteine-containing peptides. 
Finally, the advantages of a highly preorganized peptide structure were 
exploited in a short, rigid tetrapeptide where two cysteines were linked by a 
turn motif (CDPPC). For comparative purposes studies were also performed 
with another, less rigid tetrapeptide ligand containing the PG unit as a turn 
inducing motif (Figure 3). 
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Figure 3. Schematic structures of the tetrapeptides with β turn inducing motifs. The 
dashed line symbolizes the H-bond in the turn present in CDPPC 
The interaction of the peptides with the metal ions were studied by UV-
vis, CD and NMR spectroscopies and ESI-MS. The stabilities of the peptide-
metal ion complexes were determined by competition reactions with well-
known ligands forming colored species with the relevant metal ions. 
III. Methods 
Terminally protected linear peptides were synthesized by solid phase 
peptide synthesis following the Fmoc protocol. For the cyclic peptides, linear 
precursors with unprotected termini were assembled by the same method. 
After cleaving the precursors off the resin, cyclization reaction was 
performed in a highly diluted solution by general coupling agents. The crude 
products were purified by reversed phase HPLC. The purity was checked by 
analytical HPLC and ESI-MS. 
Since the cysteine moieties and Cu(I) are sensitive for oxidation, all 
sample manipulations were performed in a glovebox under argon 
atmosphere. The majority of the experiments were carried out at pH = 7.4 in 
buffered media. In a few cases, pH titrations were also executed at constant 
metal-to-ligand concentration ratios. 
The typical ligand to metal charge transfer (LMCT) bands were 
followed by UV and CD spectroscopies. The concentration of the peptide 
samples was generally c ~ 30 μM and these samples were titrated by the 
addition of aliquots of the solution of the appropriate metal ion. 
The composition of the metal ion complexes was analyzed by ESI-MS 
in both positive and negative ion modes. Spectra were recorded on samples 
containing the peptide in c ~ 100 μM concentration and different equivalents 
of the appropriate metal ion. 
CDPPC CPGC
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1H NMR spectroscopy was applied for the identification of the donor 
groups participating in metal ion coordination in case of the CueR model 
peptides and for a more extensive analysis of the systems of CDPPC and 
CPGC. Complete assignment of the proton resonances in the free and Cu(I)-
bound tetrapeptides were achieved by the combination of COSY, TOCSY, 
NOESY and ROESY measurements. The composition of the Cu4(CDPPC)3 
cluster was proved by DOSY NMR experiments. Samples were prepared in 
deuterated solvents in a typical concentration of c ~ 1.0 mM. 
Hydrogen bonds between the C=Oi and NH(i+3) groups, characteristic for 
β turns, were detected by measuring the temperature coefficients of the amide 
proton resonances. NMR spectra were recorded over the temperature range 
of 278-318 K. 
Cu(I) complex stabilities were determined by competition with BCA 
(bicinchoninate anion) or BCS (bathocuproin disulfonate), I− ions competed 
with the peptides for Hg(II) and zincon was used for the determination of the 
Zn(II) complex stabilities. The withdrawal of the metal ion was followed by 
UV-vis spectroscopy. 
IV. New scientific results 
1. Mononuclear Cu(I) complexes of the CueR model peptides, EC, VC 
and HS are formed at pH = 7.4 in excess of the ligands and these transform 
into polynuclear species in the presence of Cu(I) excess. Based on the 
observed thiolate to Cu(I) charge transfer transitions in the UV and CD 
spectra, Cu(I) is bound by the two cysteine residues of the ligands. 1H NMR 
spectra indicates the involvement of the histidine residue of HS in metal ion 
coordination. 
2. The complex formation is complete above pH = 7.0 and the decrease of 
pH leads to the decoordination of the cysteines in two steps. Apparent pKa1 = 
1.3-3.0 and pKa2 = 3.6-5.5 constants were determined for the two successive 
protonation accompanying the reverse processes. 
3. The logβ11pH7.4 ~ 16 stabilities of the mononuclear complexes at pH = 
7.4 are rather large and similar to those obtained for peptides incorporating 
the CxxC or the CxxxxC motif. This result shows that the length of the spacer 
between the Cys residues affects little the affinity towards Cu(I). Therefore, 
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the driving force for the coordination of the soft Cu(I) cation is expected to 
be mainly the formation of the two strong bonds with the soft thiolate donors. 
 
4. Striking differences were observed in the coordination of Cu(I) and 
Hg(II) by the series of three-cysteine containing peptides incorporating the 
CxCxxC and CxCxC motifs, typically appearing in metallothioneins. The 
peptides proved to be too flexible to control the speciation of Cu(I) complexes 
and hereby leading to the formation of several species, but they are adapted 
for an efficient trithiolate coordination of Hg(II). Mononuclear HgP 
complexes are formed in the presence of ligand excess and Hg(II) is 
coordinated by all the three Cys residues of the peptides. In the presence of 
Hg(II) excess, the mononuclear complexes transform into polymetallic 
species adopting the more favorable HgS2 coordination mode. The observed 
difference demonstrates that the use of Hg(II) as a probe for Cu(I) 
coordination with sulfur-rich peptides or proteins under physiological 
conditions may not always be fully appropriate. 
5. Structural differences in the three-cysteine containing peptides have 
minor effect on the affinity of the ligands towards Cu(I) and Hg(II) ions. 
Furthermore, these differences influence little the pH dependent 
transformation between the HgS2 and HgS3 species. 
5.1. All the six peptides have similar overall affinities for Cu(I) that reflect 
remarkable Cu(I)-capturing abilities of the peptides. The logβ11pH7.4 ~ 18 
apparent stability constants of the theoretical mononuclear CuP complexes 
are in the range of Cu(I) chaperon proteins. 
5.2. The apparent stabilities of the HgP complexes determined at pH = 2.0 
fall in the narrow range of logβ11pH2.0 = 27.0-27.5. The apparent stability 
constants estimated for pH = 7.4 reflect a more than 20 orders of magnitude 
larger affinity of the peptides for Hg(II) than for Cu(I) due to the significantly 
larger thiophilicity of Hg(II). Stabilities of the HgP complexes are of the same 
magnitude as that of the Hg(II) complex of the well-known heavy metal 
chelator BAL. 
5.3. UV-pH titrations showed an HgS2 ⇌ HgS3 transformation with 
pKa = 4.3-5.1 values characterizing the deprotonation of the third cysteine 
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thiol. The observed tendency of pKa values reveal that the CxCxxC motif in 
P3C is more favorable for the formation of the HgS3 structure, just like the 
longer distance from the turn motif in 2C and 3C compared to 1C, and the 
cyclic structure against the linear. 
 
6. Preorganization of the peptide structure is a key element in the control 
of Cu(I) complex speciation and in the affinity of the ligands for Cu(I). 
6.1. UV, CD and NMR titrations reveal that CDPPC forms a single Cu(I) 
complex up to 1.33 equivalents of Cu(I). The results of DOSY NMR and ESI-
MS experiments prove that this species is a Cu4P3 cluster with a Cu4S6 core 
where the Cu(I) ions are in a highly favorable trithiolate coordination 
environment. It is worth to note that this simple peptide is able to mimic the 
Cu(I)-thiolate cluster formation that are typical in proteins like Ctr1 or 
Cox17. 
6.2. The CPGC-Cu(I) system is characterized by a more complicated 
complex formation. Since the PG motif provides higher flexibility, the 
peptide cannot control the speciation of the Cu(I) complexes. 
6.3. The apparent stability constant calculated for a theoretical CuP 
mononuclear complex is one order of magnitude larger for CDPPC 
(logβ11pH7.4 = 17.5) than for CPGC (logβ11pH7.4 = 16.4). 
7. The Zn(II) complexes of CDPPC and CPGC were demonstrated to be 
mononuclear ZnP or ZnP2 species. The apparent stability constants at 
physiological pH calculated for the ZnP complexes are in a magnitude of 106, 
and the selectivity in favor of Cu(I) with respect to Zn(II) is therefore 
extremely large. 
8. Since CDPPC forms a single Cu4P3 cluster with high stability and 
displays large selectivity for Cu(I) with respect to the ubiquitous Zn(II), it is 
an interesting simple peptide candidate to be targeted to the liver cells for the 
localized treatment of Cu overload in Wilson’s disease. 
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